The outlook of companies tied to flagship drugs like Viagra presents a complex investment scenario . While the initial boom of copyright, fueled by Viagra's remarkable popularity, generated substantial returns, https://maefmlw095443.prublogger.com/40073028/sildenafil-and-its-maker-and-big-pharma-a-risky-investment